Popular Articles

Senate HELP Committee's Health Reform Bill Gives Needed Relief For America's Families
Senator Christopher Dodd, who is presiding over the Senate Health, Education, Labor and Pensions Committee during the absence of Committee Chair Edward Kennedy, today released the remaining portions of the health care reform bill that the Committee will consider when the July 4th recess ends. The following is the statement of Ron Pollack, Executive Director of Families USA, about the bill:
generic viagra online
Risk Factors For Sleep Disordered Breathing In Children: Waist Size And Body Mass Index
A study in the June 1 issue of the journal SLEEP found that waist circumference and body mass index (BMI) are consistent, independent risk factors for all severity levels of sleep disordered breathing (SDB) in children, suggesting that as with adult SDB, metabolic factors are important risk factors for childhood SDB.
News of the day
The Dioxin Poisoning Of Victor Yushchenko: Need For Methods In Routine Analysis Of Metabolites Of The Poison TCDD
An article published Online First exposes the facts of the poisoning of Ukrainian President Victor Yushchenko in 2004. It is the work of Professor Jean Saurat, from the Swiss Centre for Human Applied Toxicology, and the University Hospital, in Geneva, Switzerland, and his collaborators. It establishes that there is a need for routine analytical techniques to test for metabolites of TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) which is a type of dioxin and the poison that was used. This will help to provide proper treatment.
Cardiovascular

Rheumatoid Arthritis Is Worse In Poorer Countries

People in less affluent countries appear to suffer from more severe rheumatoid arthritis (RA) than people in wealthy countries, suggests research published ahead of print in the Annals of the Rheumatic Diseases. A study of 25 mostly European countries showed that the clinical status of patients with RA was inversely correlated with each country"s gross domestic product (GDP). Dr Tuulikki Sokka from Jyvaskyla Central Hospital in Finland and other members of the Quantitative Standard Monitoring of Patients with RA (QUEST-RA) programme, studied clinical and questionnaire data from 6,004 patients who were seen in usual care at 71 rheumatology clinics in 25 countries, including 18 European countries, between 2005 and April 2008. All patients were assessed according to a standard protocol to evaluate RA, including a formal medical examination, laboratory measures, and a patient self-report health assessment questionnaire. Data were also gathered on use of disease-modifying anti-rheumatic drugs. Patient data were analysed together with the gross domestic product (GDP) for each country. They found that patients in low GDP countries had statistically significantly higher disease activity levels in all disease activity measures, despite the fact that all patients had access to a rheumatologist and had received drugs to modify their condition. Disparities in health, including high mortality rates, are recognised to be associated with low socioeconomic status in many specific diseases in many countries. The burden of chronic diseases is recognised as an important neglected global issue, say the authors, and is heaviest in low and middle-income countries. This study, said the authors, indicates a need for more medical research in low GDP countries, as most previously published data have been derived from western European and North American nations. The authors conclude "Public health efforts would appear potentially to be as important as the introduction of new therapies to treat RA. "The burden of arthritis appears substantially greater in "low GDP" than in "high GDP" countries. These findings may alert healthcare professionals and designers of health policy towards improving the clinical status of patients with RA in all countries." "Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database." Ann Rheum Dis 2009; doi 10.1136/ard.2009.109983 Annals of the Rheumatic Diseases


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):